Abstract
PURPOSE: Detection of bacteria-specific metabolism via positron emission tomography (PET) is an emerging strategy to image human pathogens, with dramatic implications for clinical practice. In silico and in vitro screening tools have recently been applied to this problem, with several monosaccharides including l-arabinose showing rapid accumulation in Escherichia coli and other organisms. Our goal for this study was to evaluate several synthetically viable arabinofuranose-derived (18) F analogs for their incorporation into pathogenic bacteria. PROCEDURES: We synthesized four radiolabeled arabinofuranose-derived sugars: 2-deoxy-2-[(18) F]fluoro-arabinofuranoses (d-2-(18) F-AF and l-2-(18) F-AF) and 5-deoxy-5-[(18) F]fluoro-arabinofuranoses (d-5-(18) F-AF and l-5-(18) F-AF). The arabinofuranoses were synthesized from (18) F(-) via triflated, peracetylated precursors analogous to the most common radiosynthesis of 2-deoxy-2-[(18) F]fluoro-d-glucose ([(18) F]FDG). These radiotracers were screened for their uptake into E. coli and Staphylococcus aureus. Subsequently, the sensitivity of d-2-(18) F-AF and l-2-(18) F-AF to key human pathogens was investigated in vitro. RESULTS: All (18) F radiotracer targets were synthesized in high radiochemical purity. In the screening study, d-2-(18) F-AF and l-2-(18) F-AF showed greater accumulation in E. coli than in S. aureus. When evaluated in a panel of pathologic microorganisms, both d-2-(18) F-AF and l-2-(18) F-AF demonstrated sensitivity to most gram-positive and gram-negative bacteria. CONCLUSIONS: Arabinofuranose-derived (18) F PET radiotracers can be synthesized with high radiochemical purity. Our study showed absence of bacterial accumulation for 5-substitued analogs, a finding that may have mechanistic implications for related tracers. Both d-2-(18) F-AF and l-2-(18) F-AF showed sensitivity to most gram-negative and gram-positive organisms. Future in vivo studies will evaluate the diagnostic accuracy of these radiotracers in animal models of infection.